Viracta Therapeutics, Inc. S-May 3. 28, 2021 16:58
This prospectus and the information incorporated by reference contain forward-looking statements based on the beliefs and assumptions of our management and on information currently available. This section should be read in conjunction with our financial statements and related notes for the year ended December 31, 2020 included in our current report on form 8-K / A filed with the SEC on March 23, 2021 and our quarterly report on form 10-Q for the three months ended March 31, 2021 and similar financial statements included in our subsequent reports on form 10-K and shape 10-Q. Statements contained or incorporated by reference in this prospectus that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements can be identified by words such as ?? believe, ?? ??to anticipate,?? ??may,?? ??strength,?? ?? can, ?? ??could,?? ?? Carry on, ?? ??depends,?? ??expect,?? ??develop,?? ??provide,?? ?? the intention, ?? ??to predict,?? ??plan,?? ?? count, ?? ?? should, ?? ??will,?? ??may,?? ??search,?? or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. You should read these statements carefully as they address future expectations, contain projections of future results of operations or financial condition, or indicate other “forward-looking” statements. information. These statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions underlying these statements.
These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those described in the “Risk Factors” section. These forward-looking statements reflect our beliefs and opinions with respect to future events and are based on estimates and assumptions as of the date of this prospectus and are subject to risks and uncertainties. Several of these risks are discussed in more detail in the section entitled “Risk Factors”. and elsewhere in this prospectus, including information incorporated by reference. In view of these uncertainties, you should not place undue reliance on these forward-looking statements. We qualify all forward-looking statements in this prospectus by these cautionary statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in forward-looking statements, whether in due to new information, future events or otherwise.
In addition, statements that “we believe”. and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this prospectus, and while we believe that such information constitutes a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read. as indicating that we have conducted a thorough investigation or review of all relevant information potentially available. These statements are inherently uncertain and investors are cautioned not to place undue reliance on such statements.
Other unknown or unforeseeable factors could also adversely affect our results. Therefore, the actual results or developments that we predict may not be realized or, even if they are substantially realized, may not have the expected consequences or effects on us. In view of these uncertainties, potential investors are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, we do not undertake any obligation to publicly update or revise any of the forward-looking statements after the date of this prospectus.
This prospectus and the information incorporated by reference also contain estimates, projections and other information relating to our industry, business and markets for certain diseases, including data relating to the estimated size of those markets. Information based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from the events and circumstances reflected in such information. Unless expressly stated otherwise, we have obtained this industry, company, market and other data from reports, research surveys, studies and similar data prepared by market research companies and other third parties, industry, medical and general publications, government data, etc. sources.